BindingDB logo
myBDB logout

null

SMILES: NC(=O)c1cn(nc1Nc1ccc(cc1)C(F)(F)F)C1(CC#N)CCC(CC1)N1CC(F)C1

InChI Key: InChIKey=XGPGNLBIUUNYJN-UHFFFAOYSA-N

Find this compound or compounds like it in BindingDB or PDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 229391   
Target/Host
(Institution)
LigandTarget/Host
Links
Ligand
Links
Trg + Lig
Links
Ki
nM
ΔG°
kcal/mole
IC50
nM
Kd
nM
EC50/IC50
nM
koff
s-1
kon
M-1s-1
pHTemp
°C
Tyrosine-protein kinase JAK1


(Homo sapiens (Human))
BDBM229391
PNG
(US9328099, 39-2)
Show SMILES NC(=O)c1cn(nc1Nc1ccc(cc1)C(F)(F)F)C1(CC#N)CCC(CC1)N1CC(F)C1 |(4.72,5.14,;3.23,4.74,;2.14,5.83,;2.83,3.25,;1.37,2.78,;1.37,1.24,;2.83,.76,;3.74,2.01,;5.22,1.61,;5.62,.12,;7.11,-.28,;7.51,-1.77,;6.42,-2.85,;4.93,-2.46,;4.53,-.97,;6.82,-4.34,;5.73,-5.43,;8.31,-4.74,;7.22,-5.83,;.03,.47,;1.37,-.3,;1.37,-1.84,;1.37,-3.38,;-.74,-.87,;-2.28,-.87,;-3.05,.47,;-2.28,1.8,;-.74,1.8,;-4.59,.47,;-5.68,1.56,;-6.77,.47,;-8.31,.47,;-5.68,-.62,)|
Show InChI InChI=1S/C22H24F4N6O/c23-15-11-31(12-15)17-5-7-21(8-6-17,9-10-27)32-13-18(19(28)33)20(30-32)29-16-3-1-14(2-4-16)22(24,25)26/h1-4,13,15,17H,5-9,11-12H2,(H2,28,33)(H,29,30)
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 0.100n/an/an/an/an/a25



Merck Sharp & Dohme Corp.

US Patent


Assay Description
The reactions employed a common peptide substrate, LCB-EQEDEPEGDYFEWLW-NH2 (in-house). The basic assay protocol is as follows: First, 250 nL of dilut...


US Patent US9328099 (2016)


BindingDB Entry DOI: 10.7270/Q2M61J42
More data for this
Ligand-Target Pair
Tyrosine-protein kinase JAK2


(Homo sapiens (Human))
BDBM229391
PNG
(US9328099, 39-2)
Show SMILES NC(=O)c1cn(nc1Nc1ccc(cc1)C(F)(F)F)C1(CC#N)CCC(CC1)N1CC(F)C1 |(4.72,5.14,;3.23,4.74,;2.14,5.83,;2.83,3.25,;1.37,2.78,;1.37,1.24,;2.83,.76,;3.74,2.01,;5.22,1.61,;5.62,.12,;7.11,-.28,;7.51,-1.77,;6.42,-2.85,;4.93,-2.46,;4.53,-.97,;6.82,-4.34,;5.73,-5.43,;8.31,-4.74,;7.22,-5.83,;.03,.47,;1.37,-.3,;1.37,-1.84,;1.37,-3.38,;-.74,-.87,;-2.28,-.87,;-3.05,.47,;-2.28,1.8,;-.74,1.8,;-4.59,.47,;-5.68,1.56,;-6.77,.47,;-8.31,.47,;-5.68,-.62,)|
Show InChI InChI=1S/C22H24F4N6O/c23-15-11-31(12-15)17-5-7-21(8-6-17,9-10-27)32-13-18(19(28)33)20(30-32)29-16-3-1-14(2-4-16)22(24,25)26/h1-4,13,15,17H,5-9,11-12H2,(H2,28,33)(H,29,30)
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 3n/an/an/an/an/a25



Merck Sharp & Dohme Corp.

US Patent


Assay Description
The reactions employed a common peptide substrate, LCB-EQEDEPEGDYFEWLW-NH2 (in-house). The basic assay protocol is as follows: First, 250 nL of dilut...


US Patent US9328099 (2016)


BindingDB Entry DOI: 10.7270/Q2M61J42
More data for this
Ligand-Target Pair